Deckert J, Marangos P J
Life Sci. 1986 Aug 25;39(8):675-83. doi: 10.1016/0024-3205(86)90014-7.
Prostaglandin A1 and hormones like corticosteroids and DL-Thyroxin (T4) inhibit binding of [3H]RO 5-4864 and [3H] Clonazepam to their respective binding sites with inhibition constants in the low micromolar range. The corticosteroid Cortisone inhibits [3H] RO 5-4864, but not [3H] Clonazepam binding in a competitive manner with an inhibition constant of 4.3 +/- 0.7 microM, Prostaglandin A1 inhibits [3H] Clonazepam, but not [3H] RO 5-4864 binding in a competitive manner with an inhibition constant of 6 +/- 1.2 microM and DL-Thyroxin (T4) inhibits both [3H] RO 5-4864 and [3H] Clonazepam binding with inhibition constants of 12.1 +/- 2.2 and 1.6 +/- 0.4 microM respectively. While the inhibition of [3H] RO 5-4864 binding by DL-Thyroxin (T4) is competitive, the inhibition of [3H] Clonazepam binding is of the mixed type as indicated by Scatchard Plot.
前列腺素A1以及皮质类固醇和DL-甲状腺素(T4)等激素会抑制[3H]RO 5-4864和[3H]氯硝西泮与其各自结合位点的结合,抑制常数在低微摩尔范围内。皮质类固醇可的松以竞争性方式抑制[3H]RO 5-4864,但不抑制[3H]氯硝西泮的结合,抑制常数为4.3±0.7微摩尔;前列腺素A1以竞争性方式抑制[3H]氯硝西泮,但不抑制[3H]RO 5-4864的结合,抑制常数为6±1.2微摩尔;DL-甲状腺素(T4)抑制[3H]RO 5-4864和[3H]氯硝西泮的结合,抑制常数分别为12.1±2.2和1.6±0.4微摩尔。虽然DL-甲状腺素(T4)对[3H]RO 5-4864结合的抑制是竞争性的,但如Scatchard图所示,对[3H]氯硝西泮结合的抑制是混合型的。